Navigation Links
The Crohn's & Colitis Foundation and Procter & Gamble Pharmaceuticals Announce 2009 Celebrating UC Success Contest Winners
Date:6/24/2009

Winners awarded with trip to California to participate in the Foundation's Orange County Take Steps event

NEW YORK, June 24 /PRNewswire/ -- The Crohn's & Colitis Foundation, in partnership with Procter & Gamble Pharmaceuticals (P&GP), announces six winners from the second annual Celebrating UC Success essay contest. Established in December 2007, Celebrating UC Success is a program that honors people who have found personal ways to manage their ulcerative colitis (UC), a form of inflammatory bowel disease. The program highlights their successes to educate and inspire other patients and UC supporters. This year's winners are being awarded a trip for two to participate in the Foundation's Take Steps walk in Orange County, California on June 28, where they will be able to meet with others affected by UC and take part in Take Steps festivities.

Building on last year's contest, which accepted essays describing patient success over the challenges of UC, this year's contest called for UC Quick Tips -- specific, "tried and true" lifestyle tips that people affected by UC have discovered through experience to help manage their disease on a daily basis. This year's contest accepted essays and video submissions, with a goal to identify ways to help patients take steps to potentially achieve their own success.

"Because UC impacts patients' lives on a daily basis, it is important that they are armed with simple techniques that can help make each day a little bit easier," said Kimberly Frederick, Vice President of Patient and Professional Services for the Foundation. "We recognize that many UC patients are able to live full, rich lives despite the challenges that accompany their disease. Through this year's contest, we wanted these patients to share their knowledge and learnings from their experiences to help others achieve daily success with their disea
'/>"/>

SOURCE Crohn's & Colitis Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Mouse Study Gives Clues to Colitis
2. New therapeutic targets in the treatment of ulcerative colitis
3. Narrow band imaging colonoscopy identifies flat dysplastic lesions in ulcerative colitis patients
4. Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients Lives
5. Although Remicade and Humira Are Being Increasingly Prescribed for Crohns Disease and Ulcerative Colitis, Insurers Are Subjecting Both Drugs to Multiple Cost-Control Strategies
6. Shire Launches Patient Education Forums on Better Managing the Challenges of Ulcerative Colitis
7. Medical Futures signs North American licensing rights to New Biologic agent for Ulcerative Colitis
8. A rare case of ischemic colitis caused by chronic venous insufficiency
9. Study underway to find an alternative cure for Crohns disease and ulcerative colitis
10. Long-Term Safety Data on Lialda(TM) (mesalamine) for Patients With Ulcerative Colitis Published in Leading GI Journal
11. Can rectal vitamin E induce remission in patients with mild to moderate ulcerative colitis?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... harvested from San Antonio Bay ,, SILVER SPRING, ... Drug Administration is advising consumers to avoid eating oysters ... Nov. 16 due to reports of norovirus-associated illnesses in ... area, which is located on the Gulf of Texas. ... The FDA, along with the Centers for Disease Control ...
(Date:12/6/2009)... Findings offer hope for future treatments targeting growth factor, ... -- The spread of breast cancer cells from the ... controlled by a growth factor known as TGFb, which ... prevent metastatic breast cancer, British researchers say. , Previous ... regulates normal cell growth and movement. In this new ...
(Date:12/6/2009)... NEW ORLEANS, Dec. 6 Onyx Pharmaceuticals, ... safety data from the pivotal Phase 2b 003-A1 ... carfilzomib is well-tolerated in heavily pre-treated relapsed and ... today at the ASH/ASCO Joint Symposium at the ... Hematology (ASH) in New Orleans. Enrollment in this ...
(Date:12/6/2009)... new study provides welcome news for patients with a ... , The condition is estimated to impact 62,000 Canadians ... abnormal clot forms in a vein and restricts the ... cases, the clot may detach from its point of ... causing a potentially fatal condition known as a pulmonary ...
(Date:12/6/2009)... dangerous substances such as asbestos have been found in toys in ... ... December 6, 2009 -- As parents shop for children,s toys during ... due to lead paint or asbestos contamination, says a New York ... rooms each year due to toy-related injuries,” says Joseph W. Belluck, ...
Breaking Medicine News(10 mins):Health News:FDA, CDC, and States Investigating Norovirus Illnesses Linked to Oysters 2Health News:Breast Cancer's Spread Now Better Understood 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 2Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 3Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 4Health News:Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability 5Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 2Health News:Belluck & Fox Law Firm Urges Caution When Buying Toys This Holiday Season 3
... 12 Rite Aid Corporation (Rite Aid) and nine ... pay $5 million in civil penalties to settle allegations ... Department of Justice announced today. In addition to the ... subsidiaries agreed to a compliance plan with the U.S. ...
... EDITOR,S PICK: Opiods provide relief from neuropathic pain ... nerves, such as caused by the trauma of amputation, ... can be extremely debilitating, and treatments show limited or ... with an inflammatory response, and immune cells are thought ...
... Holdings, Inc.,(NYSE: ZMH ; SWX: ZMH) announced ... has been appointed to its Board of Directors. ... other publicly traded,companies. , "Betsy ... leading,large, consumer-facing organizations in competitive, highly regulated,markets," said John ...
... Americans in Fighting the Country,s Most Common DisabilityATLANTA, Jan. ... of Let,s Move Together , a nationwide movement ... one-in-five Americans living with the pain of arthritis.To view ... Let,s Move Together is designed to inspire ...
... Stereotaxis, Inc.,(Nasdaq: STXS ) today announced ... the RF PowerAssert(TM) Magnetic Guidewire. Cleared by ... RF PowerAssert guidewire is the only,magnetically enabled device ... with the Niobe Magnetic Navigation System, it is ...
... eyes read 29 words per minute slower , , MONDAY, ... reading problems in older adults, a new report shows. , ... found people with glaucoma in both eyes (bilateral) read 29 ... were almost twice as likely to have reading impairment. , ...
Other Medicine News:Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 2Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 3Health News:Rite Aid Corporation and Subsidiaries Agree to Pay $5 Million in Civil Penalties to Resolve Violations in Eight States of the Controlled Substances Act 4Health News:JCI online early table of contents: Jan. 12, 2009 2Health News:JCI online early table of contents: Jan. 12, 2009 3Health News:JCI online early table of contents: Jan. 12, 2009 4Health News:JCI online early table of contents: Jan. 12, 2009 5Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 2Health News:Zimmer Holdings Names Betsy Bernard to Board of Directors 3Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 2Health News:Photos: Arthritis Foundation Launches Nationwide Movement Encouraging People to Move to Prevent and Treat Arthritis 3Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 2Health News:Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire 3
(Date:12/4/2009)... AstraZeneca (NYSE: AZN ) today announced ... approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets ... Major Depressive Disorder (MDD). SEROQUEL XR is the only ... treat both major depressive disorder as adjunctive therapy and ...
(Date:12/3/2009)... a subsidiary of Hill-Rom Holdings, Inc. (NYSE: ... Allen Amatech(TM) OEM (Original Equipment Manufacturer) business website ... the Allen Amatech(TM) brand identity and includes an online ... and design specifications for the products. "We hope to ...
(Date:12/3/2009)... Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), ... small molecule drugs for the treatment of immune mediated ... a webcast and conference call on, Tuesday, December 8, ... 8:00am Pacific Time) to discuss clinical data regarding its ...
Breaking Medicine Technology:US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 2US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 3US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 4US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 5US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 6US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 7US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 8US FDA Approves SEROQUEL XR(R) For Add-On Treatment of Major Depressive Disorder 9Allen Medical Systems Announces the Launch of New Allen Amatech(TM) OEM Website 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment 14893 1Entest BioMedical Files 3rd Patent Application for COPD Stem Cell Treatment 14893 2Huge Exhibition to Demonstrate Training for Irregular Warfare 14892 1Huge Exhibition to Demonstrate Training for Irregular Warfare 14892 2Huge Exhibition to Demonstrate Training for Irregular Warfare 14892 3BioSoteria CEO to Present at Drug Safety Conference 14889 1BioSoteria CEO to Present at Drug Safety Conference 14889 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: